(Q21195191)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24451109%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

title

Role of the androgen receptor in breast cancer and preclinical analysis of enzalutamide (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24451109%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

1 reference

3

Britta M Jacobsen

Britta M

Jacobsen

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24451109%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

4

Diana M Cittelly

Diana M

Cittelly

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24451109%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

Dawn R Cochrane

1

Dawn R

Cochrane

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24451109%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

Sebastián Bernales

2

Sebastián

Bernales

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24451109%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

Erin N Howe

5

Erin N

Howe

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24451109%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

Nicholas C D'Amato

6

Nicholas C

D'Amato

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24451109%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

Nicole S Spoelstra

7

Nicole S

Spoelstra

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24451109%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

Susan M Edgerton

8

Susan M

Edgerton

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24451109%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

Annie Jean

9

Annie

Jean

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24451109%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

Javier Guerrero

10

Javier

Guerrero

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24451109%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

Francisco Gómez

11

Francisco

Gómez

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24451109%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

Satyanarayana Medicherla

12

Satyanarayana

Medicherla

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24451109%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

Iván E Alfaro

13

Iván E

Alfaro

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24451109%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

Emma McCullagh

14

Emma

McCullagh

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24451109%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

Paul Jedlicka

15

Paul

Jedlicka

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24451109%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

Kathleen C Torkko

16

Kathleen C

Torkko

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24451109%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

Ann D Thor

17

Ann D

Thor

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24451109%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

Anthony D Elias

18

Anthony D

Elias

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24451109%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

Andrew A Protter

19

Andrew A

Protter

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24451109%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

Jennifer K Richer

20

Jennifer K

Richer

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24451109%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

language of work or name

English

0 references

publication date

22 January 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24451109%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

published in

Breast Cancer Research

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24451109%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

volume

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24451109%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24451109%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

page(s)

R7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24451109%20AND%20SRC:MED&resulttype=core&format=json

describes a project that uses

5 March 2020

ImageJ

1 reference

11 June 2022

https://www.ebi.ac.uk/europepmc/webservices/rest/PMC3978822/fullTextXML

inferred from PubMed Central ID database lookup

cites work

Phase II trial of bicalutamide in patients with androgen receptor-positive, estrogen receptor-negative metastatic Breast Cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3978822

Targeting androgen receptor in estrogen receptor-negative breast cancer

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3978822

Development of a second-generation antiandrogen for treatment of advanced prostate cancer

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3978822

A clinically relevant androgen receptor mutation confers resistance to second-generation antiandrogens enzalutamide and ARN-509.

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3978822

Effects of the aromatase inhibitor 4-hydroxyandrostenedione and the antiandrogen flutamide on growth and steroid levels in DMBA-induced rat mammary tumors

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3978822

Increased survival with enzalutamide in prostate cancer after chemotherapy

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3978822

Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3978822

An F876L mutation in androgen receptor confers genetic and phenotypic resistance to MDV3100 (enzalutamide).

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3978822

Estrogen switches pure mucinous breast cancer to invasive lobular carcinoma with mucinous features

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3978822

Androgen receptor as a targeted therapy for breast cancer.

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3978822

Minireview: The androgen receptor in breast tissues: growth inhibitor, tumor suppressor, oncogene?

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3978822

An androgen receptor mutation in the MDA-MB-453 cell line model of molecular apocrine breast cancer compromises receptor activity

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3978822

The growth response to androgen receptor signaling in ERα-negative human breast cells is dependent on p21 and mediated by MAPK activation

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3978822

The CXCL12/CXCR4 axis promotes ligand-independent activation of the androgen receptor

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3978822

A refined molecular taxonomy of breast cancer

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3978822

Androgen receptor driven transcription in molecular apocrine breast cancer is mediated by FoxA1.

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3978822

Androgen receptor expression in breast cancer in relation to molecular phenotype: results from the Nurses' Health Study

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3978822

Androgen receptor expression and breast cancer survival in postmenopausal women

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3978822

Androgen receptor overexpression induces tamoxifen resistance in human breast cancer cells

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3978822

Bicalutamide functions as an androgen receptor antagonist by assembly of a transcriptionally inactive receptor

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3978822

Dihydrotestosterone: a rationale for its use as a non-aromatizable androgen replacement therapeutic agent

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3978822

The clinical significance of androgen receptors in breast cancer and their relation to histological and cell biological parameters

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3978822

The length and location of CAG trinucleotide repeats in the androgen receptor N-terminal domain affect transactivation function

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3978822

Androgens induce divergent proliferative responses in human breast cancer cell lines.

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3978822

Androgen receptor inhibits estrogen receptor-alpha activity and is prognostic in breast cancer

12 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3978822

Positive feedback activation of estrogen receptors by the CXCL12-CXCR4 pathway

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3978822

Role of androgens on MCF-7 breast cancer cell growth and on the inhibitory effect of letrozole

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3978822

An estrogen receptor-negative breast cancer subset characterized by a hormonally regulated transcriptional program and response to androgen

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3978822

Steroid receptor regulation of epidermal growth factor signaling through Src in breast and prostate cancer cells: steroid antagonist action

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3978822

Coregulator recruitment and histone modifications in transcriptional regulation by the androgen receptor.

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3978822

Characterization of androgen receptor and nuclear receptor co-regulator expression in human breast cancer cell lines exhibiting differential regulation of kallikreins 2 and 3.

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3978822

A novel cell line, MDA-kb2, that stably expresses an androgen- and glucocorticoid-responsive reporter for the detection of hormone receptor agonists and antagonists

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3978822

Interactions between androgen and estrogen receptors and the effects on their transactivational properties

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3978822

MDA-MB-453, an androgen-responsive human breast carcinoma cell line with high level androgen receptor expression

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3978822

Apocrine carcinoma as triple-negative breast cancer: novel definition of apocrine-type carcinoma as estrogen/progesterone receptor-negative and androgen receptor-positive invasive ductal carcinoma

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3978822

30 May 2018

Androgens and the breast

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3978822

Identification of molecular apocrine breast tumours by microarray analysis.

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3978822

Stromal cell-derived factor 1, a novel target of estrogen receptor action, mediates the mitogenic effects of estradiol in ovarian and breast cancer cells

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3978822

In vitro growth promotion of human mammary carcinoma cells by steroid hormones, tamoxifen, and prolactin

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3978822

Androgens inhibit basal and estrogen-induced cell proliferation in the ZR-75-1 human breast cancer cell line

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3978822

Androgens and musculoskeletal symptoms among breast cancer patients on aromatase inhibitor therapy

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3978822

Androgen receptor in breast cancer: expression in estrogen receptor-positive tumors and in estrogen receptor-negative tumors with apocrine differentiation

29 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3978822

Expression of androgen receptors in primary breast cancer

29 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3978822

Antiproliferative actions of the synthetic androgen, mibolerone, in breast cancer cells are mediated by both androgen and progesterone receptors.

29 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3978822

Estrogen regulated gene expression in response to neoadjuvant endocrine therapy of breast cancers: tamoxifen agonist effects dominate in the presence of an aromatase inhibitor

29 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3978822

Molecular signatures of neoadjuvant endocrine therapy for breast cancer: characteristics of response or intrinsic resistance

29 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3978822

Phase III study of letrozole versus tamoxifen as first-line therapy of advanced breast cancer in postmenopausal women: analysis of survival and update of efficacy from the International Letrozole Breast Cancer Group

29 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3978822

High dehydroepiandrosterone-sulfate predicts breast cancer progression during new aromatase inhibitor therapy and stimulates breast cancer cell growth in tissue culture: a renewed role for adrenalectomy

29 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3978822

Prostate-specific antigen decline after casodex withdrawal: evidence for an antiandrogen withdrawal syndrome

29 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3978822

Failure of 5α-Dihydrotestosterone To Elicit Estrous Behavior in the Ovariectomized Rabbit

29 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3978822

Failure of 5α-Dihydrotestosterone to initiate Sexual Behaviour in the Castrated Male Rat

29 November 2018

1 reference

12 December 2020

Testosterone, dihydrotestosterone and oestradiol levels in postmenopausal breast cancer tissues

1 reference

12 December 2020

Androgens and androgen receptors: a clinically neglected sector in breast cancer biology

1 reference

12 December 2020

Androgen receptors in operable breast cancer: relation to other steroid hormone receptors, correlations to prognostic factors and predictive value for effect of adjuvant tamoxifen treatment

1 reference

12 December 2020

FACT: an open-label randomized phase III study of fulvestrant and anastrozole in combination compared with anastrozole alone as first-line therapy for patients with receptor-positive postmenopausal breast cancer

1 reference

12 December 2020

Biological aromatization of steroids

1 reference

12 December 2020

Identifiers

DOI

10.1186/BCR3599

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24451109%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

5 March 2020

1025546025

0 references

1 reference

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24451109%20AND%20SRC:MED&resulttype=core&format=json

5 March 2020

PubMed publication ID

24451109

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24451109%20AND%20SRC:MED&resulttype=core&format=json